Press release
COVID-19 Pipeline Outlook Report 2024 | Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A., TC BioPharm, Syntax for Science, S.L, Shaperon, and others.
COVID-19 Pipeline
Key Takeaways from the COVID-19 Pipeline Report
• DelveInsight's COVID-19 pipeline report depicts a robust space with 400+ active players working to develop 400+ pipeline therapies for COVID-19 treatment.
• The leading companies working in the COVID-19 Market include Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A., TC BioPharm, Syntax for Science, S.L, Shaperon, Renibus Therapeutics, Quercis Pharma, Pharmenterprises, Pharmamel S.L., Orpheris, OPKO Health, Oncotelic Inc., Notitia Biotechnologies Company, Jazz Pharmaceuticals, Ionis Pharmaceuticals, Inotrem, Grifols Therapeutics LLC, Grifols Therapeutics LLC, Globavir Biosciences, Genentech, Inc., FSD Pharma, Faron Pharmaceuticals, Evergreen Therapeutics, Enlivex Therapeutics, Eiger BioPharmaceuticals, Direct Biologics, Debiopharm, Clene Nanomedicine, Chiesi Farmaceutici S.p.A., Cadila Healthcare Limited, Biotest, BeiGene, Apeiron Biologics, AgelessRx, AbbVie/Apotex, Telios Pharmaceuticals, Rapa Therapeutics, Organicell Regenerative Medicine, Miltenyi Biomedicine, MedRegen LLC, Kiadis Pharma, Kamada, Cellularity Incorporated, Bio-Thera Solutions, 3M, Sironax, Pfizer, Oncovir, Ology Bioservices, Neutrolis, NeoImmune Tech, Natureceuticals Sdn Bhd, Medicine Invention, Kiadis Pharma, Grand Medical, Frontier Biotechnologies, Emergent Biosolutions, Codagenix, Cellenkos, AlloVir, Bausch Health Americas, AiCuris, AgenTus Therapeutics, 4D Pharma, and others.
• Promising COVID-19 Pipeline Therapies in the various stages of development include AZD1222, AZD7442, Plitidepsin 1.5 mg/day, Acalabrutinib, Sarilumab, ZF2001, Bamlanivimab, AT-527, and others.
• September 2023: Guangzhou Patronus Biotech Co., Ltd. announced a study of Phase 3 clinical trials for Recombinant SARS-CoV-2 Vaccine (CHO Cell) LYB001 and ZF2001. The study is a randomized, double-blind, positive control design and 1200 subjects are randomly assigned to LYB001 and positive control groups in a 1:1 ratio to evaluate the safety and immunogenicity as a booster vaccination.
• September 2023: BioNTech SE announced a study of Phase 2 & 3 Clinical Trials for BNT162b2 30mcg. This is a Phase 1/2/3 study in healthy children. Dependent upon safety and/or immunogenicity data generated during the course of this study, and the resulting assessment of benefit-risk, the safety, tolerability, and immunogenicity of BNT162b2 in participants
Request a sample and discover the recent advances in COVID-19 Treatment Drugs @ COVID-19 Pipeline Report- https://www.delveinsight.com/report-store/covid-19-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
In the COVID-19 Pipeline Report, a detailed description of the drug is given which includes the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, COVID-19 collaborations, licensing, mergers and acquisition, funding, designations, and other product-related details.
COVID-19 Overview
Coronavirus disease (COVID-19) is an infectious disease caused by the most recently discovered corona virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The disease causes respiratory illness (like the flu) with symptoms such as a cough, fever, and difficulty breathing.
Find out more about COVID-19 Therapeutics Assessment @ COVID-19 Preclinical and Discovery Stage Products- https://www.delveinsight.com/sample-request/covid-19-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
COVID-19 Emerging Drugs Profile
• REGN-COV2: Regeneron Pharmaceuticals
• Bucillamine: Revive Therapeutics
• Mupadolimab (CPI-006): Corvus Pharmaceuticals
• VERU 111: Veru Inc.
• Sarconeos (BIO101): Biophytis
• Leronlimab: CytoDyn
• Tocilizumab: Hoffmann-La Roche
COVID-19 Pipeline Therapeutics Assessment
There are approx. 400+ key companies which are developing the COVID-19 therapies. The COVID-19 companies that have their COVID-19 drug candidates in the most advanced stage, i.e. phase III include Regeneron Pharmaceuticals.
Learn more about the emerging COVID-19 Pipeline Therapies @ COVID-19 Clinical Trials Assessment- https://www.delveinsight.com/sample-request/covid-19-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Scope of the COVID-19 Pipeline Report
• Coverage- Global
• COVID-19 Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
• COVID-19 Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III
• COVID-19 Companies- Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A., TC BioPharm, Syntax for Science, S.L, Shaperon, Renibus Therapeutics, Quercis Pharma, Pharmenterprises, Pharmamel S.L., Orpheris, OPKO Health, Oncotelic Inc., Notitia Biotechnologies Company, Jazz Pharmaceuticals, Ionis Pharmaceuticals, Inotrem, Grifols Therapeutics LLC, Grifols Therapeutics LLC, Globavir Biosciences, Genentech, Inc., FSD Pharma, Faron Pharmaceuticals, Evergreen Therapeutics, Enlivex Therapeutics, Eiger BioPharmaceuticals, Direct Biologics, Debiopharm, Clene Nanomedicine, Chiesi Farmaceutici S.p.A., Cadila Healthcare Limited, Biotest, BeiGene, Apeiron Biologics, AgelessRx, AbbVie/Apotex, Telios Pharmaceuticals, Rapa Therapeutics, Organicell Regenerative Medicine, Miltenyi Biomedicine, MedRegen LLC, Kiadis Pharma, Kamada, Cellularity Incorporated, Bio-Thera Solutions, 3M, Sironax, Pfizer, Oncovir, Ology Bioservices, Neutrolis, NeoImmune Tech, Natureceuticals Sdn Bhd, Medicine Invention, Kiadis Pharma, Grand Medical, Frontier Biotechnologies, Emergent Biosolutions, Codagenix, Cellenkos, AlloVir, Bausch Health Americas, AiCuris, AgenTus Therapeutics, 4D Pharma, and others.
• COVID-19 Pipeline Therapies- AZD1222, AZD7442, Plitidepsin 1.5 mg/day, Acalabrutinib, Sarilumab, ZF2001, Bamlanivimab, AT-527, and others.
Dive deep into rich insights for new drugs for COVID-19 Treatment, Visit @ COVID-19 Market Drivers and Barriers, and Future Perspective- https://www.delveinsight.com/sample-request/covid-19-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Table of Content
1. Introduction
2. Executive Summary
3. COVID-19: Overview
4. Pipeline Therapeutics
5. Therapeutic Assessment
6. Late Stage Products (Phase III)
7. REGN-COV2: Regeneron Pharmaceuticals
8. Drug profiles in the detailed report…..
9. Mid Stage Products (Phase II)
10. CNM-ZnAg: Clene Nanomedicine
11. Drug profiles in the detailed report…..
12. Early Stage Products (Phase I)
13. SIR1-365: Sironax
14. Drug profiles in the detailed report…..
15. Preclinical and Discovery Stage Products
16. SB019: Novan
17. Drug profiles in the detailed report…..
18. Inactive Products
19. COVID-19 Key Companies
20. COVID-19 Key Products
21. COVID-19- Unmet Needs
22. COVID-19- Market Drivers and Barriers
23. COVID-19- Future Perspectives and Conclusion
24. COVID-19 Analyst Views
25. COVID-19 Key Companies
26. Appendix
For further information on the COVID-19 Pipeline therapeutics, reach out to COVID-19 Unmet Needs and Analyst Views- https://www.delveinsight.com/sample-request/covid-19-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
List of Important Links-
https://germanydennydones.bloggip.com/profile
https://germanydennydones.creacionblog.com/profile
https://germanydennydones.dm-blog.com/profile
https://germanydennydones.tusblogos.com/profile
https://germanydennydones.spintheblog.com/profile
https://germanydennydones.dailyblogzz.com/profile
https://germanydennydones.bloginder.com/profile
https://germanydennydones.blogvivi.com/profile
https://germanydennydones.bleepblogs.com/profile
https://germanydennydones.get-blogging.com/profile
https://germanydennydones.targetblogs.com/profile
https://germanydennydones.newsbloger.com/profile
https://germanydennydones.blogdal.com/profile
https://germanydennydones.ja-blog.com/profile
https://germanydennydones.blogscribble.com/profile
https://germanydennydones.madmouseblog.com/profile
https://germanydennydones.activoblog.com/profile
https://germanydennydones.blog-ezine.com/profile
https://germanydennydones.blogtov.com/profile
https://germanydennydones.digitollblog.com/profile
https://germanydennydones.blazingblog.com/profile
https://germanydennydones.smblogsites.com/profile
https://germanydennydonesc.weblogco.com/profile
https://germanydennydones.blogdeazar.com/profile
https://germanydennydones.eedblog.com/profile
https://germanydennydones.theisblog.com/profile
https://germanydennydones.blog2freedom.com/profile
https://germanydennydones.qodsblog.com/profile
https://germanydennydones.bloggazza.com/profile
https://germanydennydones.bloggactivo.com/profile
https://germanydennydones.bloggadores.com/profile
https://germanydennydones.blogsvirals.com/profile
https://germanydennydones.blog-gold.com/profile
https://germanydennydones.ambien-blog.com/profile
https://germanydennydones.atualblog.com/profile
https://germanydennydones.blog-a-story.com/profile
https://germanydennydones.blogacep.com/profile
https://germanydennydones.blogadvize.com/profile
https://germanydennydones.bloggerbags.com/profile
https://germanydennydones.bloggerswise.com/profile
https://germanydennydones.bloggosite.com/profile
https://germanydennydones.blogoscience.com/profile
https://germanydennydones.blogproducer.com/profile
https://germanydennydones.blogrelation.com/profile
https://germanydennydones.blogrenanda.com/profile
https://germanydennydones.blogsidea.com/profile
https://germanydennydones.blogthisbiz.com/profile
https://germanydennydones.blue-blogs.com/profile
https://germanydennydones.csublogs.com/profile
https://germanydennydones.dailyhitblog.com/profile
https://germanydennydones.develop-blog.com/profile
https://germanydennydones.livebloggs.com/profile
https://germanydennydones.is-blog.com/profile
https://hyperbookmarks.com/story16829911/atopic-dermatitis-market-size
https://hotbookmarkings.com/story16883941/atopic-dermatitis-market-outlook
https://extrabookmarking.com/story16805585/atopic-dermatitis-market-forecast
https://enrollbookmarks.com/story16793892/atopic-dermatitis-market-trends
https://digibookmarks.com/story16832272/atopic-dermatitis-treatment-market
https://bookmarktune.com/story16785555/atopic-dermatitis-market-insights
https://bookmarkpressure.com/story16812823/atopic-dermatitis-market
https://bookmarkjourney.com/story16864476/atopic-dermatitis-market-size
https://bookmarkindexing.com/story16742365/atopic-dermatitis-market-outlook
https://maximusbookmarks.com/story16970425/atopic-dermatitis-market-forecast
https://bookmarkforest.com/story16794298/atopic-dermatitis-drug-market
https://bookmarkchamp.com/story16807071/atopic-dermatitis-drug-market
https://bookmarkingquest.com/story16806001/atopic-dermatitis-drug-market
https://bookmarkingbay.com/story16763993/atopic-dermatitis-drug-market
https://active-bookmarks.com/story16761273/atopic-dermatitis-market-forecast
https://dmozbookmark.com/story16828056/atopic-dermatitis-drug-market
https://bookmarklinx.com/story16889261/atopic-dermatitis-market-outlook
https://bookmarkerz.com/story16762032/atopic-dermatitis-market-size
https://bookmarkahref.com/story16846516/atopic-dermatitis-drug-market
https://top10bookmark.com/story16738693/atopic-dermatitis-market-size
https://tinybookmarks.com/story16871257/atopic-dermatitis-market-outlook
https://thebookmarknight.com/story16844966/atopic-dermatitis-market-trends
https://scrapbookmarket.com/story16804746/atopic-dermatitis-market-share
https://royalbookmarking.com/story16846844/atopic-dermatitis-drug-market
https://nanobookmarking.com/story16794126/atopic-dermatitis-treatment-market-size
https://modernbookmarks.com/story16676860/atopic-dermatitis-treatment-market
https://listingbookmarks.com/story16875255/atopic-dermatitis-market-trends
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: ybhardwaj@delveinsight.com
Phone: 9650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/report-store/fertility-monitoring-devices-fertility-testing-devices-market
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release COVID-19 Pipeline Outlook Report 2024 | Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A., TC BioPharm, Syntax for Science, S.L, Shaperon, and others. here
News-ID: 3434973 • Views: …
More Releases from DelveInsight Business Research LLP
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight and stay ahead…
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight…
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market…
More Releases for Pharma
Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031.
The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the…
